|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,176.00 JPY | -1.18% |
|
+0.44% | +3.97% |
| 13/07 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| 11/07 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
| Market Cap | 3,898B 24.86B 21.61B 20.18B 18.52B 34.92B 2,370B 35.53B 238B 93.17B 1,182B 93.4B 91.33B | P/E 2027 * |
11.4x | P/E 2028 * | 11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3,768B 24.04B 20.89B 19.5B 17.9B 33.76B 2,291B 34.35B 230B 90.06B 1,142B 90.28B 88.28B | EV / Sales 2027 * |
1.67x | EV / Sales 2028 * | 1.65x |
| Free-Float |
97.66% | Yield 2027 * |
3.69% | Yield 2028 * | 3.81% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -1.18% | ||
| 1 week | +0.44% | ||
| Current month | -1.18% | ||
| 1 month | +1.71% | ||
| 3 months | -1.40% | ||
| 6 months | +1.19% | ||
| Current year | +3.97% |
| 1 week | 2,129.5 |  | 2,305.5 |
| 1 month | 2,109 | | 2,305.5 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,549 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.18% | +0.44% | +38.03% | +5.79% | 24.75B | |
| -2.80% | -6.82% | +45.11% | +148.43% | 1,024B | |
| -0.86% | -4.99% | +47.73% | +48.08% | 618B | |
| -2.05% | -4.33% | +24.65% | +64.91% | 443B | |
| +0.68% | -1.14% | +39.61% | +33.36% | 349B | |
| -1.66% | -3.13% | +31.63% | +39.79% | 297B | |
| -8.96% | -10.77% | +3.27% | +5.50% | 264B | |
| -1.37% | -7.41% | -3.42% | -43.67% | 209B | |
| -1.39% | +0.81% | +25.62% | +64.41% | 208B | |
| +0.05% | -0.48% | +13.44% | +71.98% | 162B | |
| Average | -2.00% | -1.05% | +26.57% | +43.86% | 359.85B | |
| Weighted average by Cap. | -2.09% | -2.14% | +32.91% | +69.90% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,260B 14.41B 12.53B 11.69B 10.74B 20.24B 1,374B 20.59B 138B 54B 685B 54.13B 52.94B | 2,079B 13.26B 11.52B 10.76B 9.88B 18.63B 1,264B 18.95B 127B 49.69B 630B 49.81B 48.71B |
| Net income | 343B 2.18B 1.9B 1.77B 1.63B 3.07B 208B 3.12B 20.9B 8.19B 104B 8.21B 8.02B | 331B 2.11B 1.83B 1.71B 1.57B 2.96B 201B 3.01B 20.18B 7.91B 100B 7.92B 7.75B |
| Net Debt | -130B -830M -721M -673M -618M -1.17B -79.08B -1.19B -7.94B -3.11B -39.44B -3.12B -3.05B | -472B -3.01B -2.62B -2.44B -2.24B -4.23B -287B -4.3B -28.82B -11.29B -143B -11.32B -11.07B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | JPY 2,176.00 | -1.18% | 7,373,300 |
| 31/07/26 | JPY 2,202.00 | -3.72% | 8,229,600 |
| 30/07/26 | JPY 2,287.00 | -0.37% | 8,531,100 |
| 29/07/26 | JPY 2,295.50 | +2.78% | 9,394,300 |
| 28/07/26 | JPY 2,233.50 | +1.06% | 7,062,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
